DNA methylation regulates mouse cardiac myofibril gene expression during heart development

Journal of Biomedical Science, Oct 2015

Background It is well known that epigenetic modifications play an important role in controlling the regulation of gene expression during the development. Our previous studies have demonstrated that the expression of fetal troponin I gene (also called slow skeletal troponin I, ssTnI) is predominated in the fetal stage, reduced after birth and disappeared in the adulthood. The mechanism underlying the developmentally related ssTnI gene regulation is not clear. In this study, we have explored the epigenetic role of DNA methylation in the regulation of ssTnI expression in the heart during the development. Results The DNA methylation levels of CpG island and CpG dinucleotides region were detected using methylation specific PCR (MSP) and bisulfite sequence PCR (BSP) in 2000 bp upstream and 100 bp upstream of ssTnI gene promoter. Real time RT-PCR and Western blot were used to detect ssTnI mRNA and protein expression levels. We found that DNA methylation levels of the CpG dinucleotides region in ssTnI gene promoter were increased with the development, corresponding to a decreased expression of ssTnI gene in mouse heart. However the DNA methylation levels of CpG islands in this gene were not changed during the development. Application of a methylation inhibitor, 5-Azacytidine, in cultured myocardial cells partially prevented the decline of ssTnI expression. Conclusion Our results indicate that DNA methylation, as an epigenetic intervention, plays a role in the regulation of the fetal TnI gene expression in the heat during the development.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

http://www.jbiomedsci.com/content/pdf/s12929-015-0203-6.pdf

DNA methylation regulates mouse cardiac myofibril gene expression during heart development

Xu et al. Journal of Biomedical Science DNA methylation regulates mouse cardiac myofibril gene expression during heart development Yang Xu 1 Lingjuan Liu 1 Bo Pan 1 Jing Zhu Changlong Nan 0 Xupei Huang 0 Jie Tian 1 0 Department of Biomedical Science, Charlie E. Schmidt College of Medicine, Florida Atlantic University , 777 Glades Road, Boca Raton, FL 33431 , USA 1 Department of Cardiology, Heart Centre, Children's Hospital of Chongqing Medical University , 136 Zhongshan 2nd Road, Yu Zhong District, Chongqing 400014, P.R. of China Background: It is well known that epigenetic modifications play an important role in controlling the regulation of gene expression during the development. Our previous studies have demonstrated that the expression of fetal troponin I gene (also called slow skeletal troponin I, ssTnI) is predominated in the fetal stage, reduced after birth and disappeared in the adulthood. The mechanism underlying the developmentally related ssTnI gene regulation is not clear. In this study, we have explored the epigenetic role of DNA methylation in the regulation of ssTnI expression in the heart during the development. Results: The DNA methylation levels of CpG island and CpG dinucleotides region were detected using methylation specific PCR (MSP) and bisulfite sequence PCR (BSP) in 2000 bp upstream and 100 bp upstream of ssTnI gene promoter. Real time RT-PCR and Western blot were used to detect ssTnI mRNA and protein expression levels. We found that DNA methylation levels of the CpG dinucleotides region in ssTnI gene promoter were increased with the development, corresponding to a decreased expression of ssTnI gene in mouse heart. However the DNA methylation levels of CpG islands in this gene were not changed during the development. Application of a methylation inhibitor, 5-Azacytidine, in cultured myocardial cells partially prevented the decline of ssTnI expression. Conclusion: Our results indicate that DNA methylation, as an epigenetic intervention, plays a role in the regulation of the fetal TnI gene expression in the heat during the development. Troponin I; DNA methylation; 5-Azacytidine; Epigenetic regulation - Background Sarcomere protein, troponin, is located on the thin filament of myocardial cells and plays an essential role in regulating Ca2+-activated tension of striated muscles. Troponin component contains three isoforms: troponin T (TnT), binding to tropomyosion forming troponintropomyosion complex, troponin C (TnC), binding to Ca2+ to produce a conformational change in TnT, and troponin I (TnI), an inhibitory subunit binding to actintropomyosion and regulating muscles contraction [1]. There are at least two developmentally regulated TnI isoforms in the heart: the slow skeletal TnI (ssTnI) that is expressed in the fetal heart and the cardiac TnI (cTnI) that is predominately expressed in adult hearts [1–3]. TnI isoform switching is common in animals and human, and it is a good model to investigate the regulation of cardiac proteins in the development [4]. It is clinically important to clarify the regulation of TnI expression, because many cardiomyopathy and heart diseases are associated with abnormal TnI protein expression leading to diastolic dysfunction and heart failure [5–7]. In our previous studies, we have demonstrated that ssTnI expression in heart is partially regulated by thyroid hormone during the heart development [8, 9]. And we have also cloned mouse ssTnI gene with upstream promoters and revealed several regions and domains on the promoters critically to ssTnI gene expression, such as TnI slow upstream regulatory elements (SURE), Yin Yang 1 factor (YY1), proximal 300 bp upstream region and the first © 2015 Xu et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. intron of ssTnI gene [10–13]. However, the mechanisms of ssTnI down-regulation and finally shut down in the heart after birth is still not clear. DNA methylation is one of epigenetic modifications and many studies have showed that DNA methylation plays an important role in gene expression, genomic imprinting, X-chromosome inactivation and chromatin structure changes [14–16]. DNA methylation occurs on position 5 of cytosine by the covalent modification of a methyl group, creating 5-methylcytosine, which is preferentially found in CpG dinucleotides [17]. The “CpG” is shorthand for “-C-phosphate-G-”, which is cytosine and guanine separated by only one phosphate. CpG island is a (...truncated)


This is a preview of a remote PDF: http://www.jbiomedsci.com/content/pdf/s12929-015-0203-6.pdf

Yang Xu, Lingjuan Liu, Bo Pan, Jing Zhu, Changlong Nan, Xupei Huang, Jie Tian. DNA methylation regulates mouse cardiac myofibril gene expression during heart development, Journal of Biomedical Science, 2015, pp. 88, 22, DOI: 10.1186/s12929-015-0203-6